← Portfolio Scout

Portfolio company

Elegen

United States · £27.6m raised

Raised

£27.6m

Latest stage

Series B

Rounds recorded

1

Backed by

2 investors

Sectors

Deep TechDigital Health

About

The company manufactures synthetic DNA using cell-free technology for biopharmaceutical and healthcare customers to develop vaccines and genetic medicines.

Source

Funding history · 1

Similar companies